Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
- Previous Close
33.50 - Open
33.75 - Bid 34.30 x --
- Ask 35.00 x --
- Day's Range
33.00 - 34.80 - 52 Week Range
27.40 - 60.10 - Volume
181,233 - Avg. Volume
91,134 - Market Cap (intraday)
2.919B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-4.73 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei City, Taiwan.
www.twbio-thera.comRecent News: 6892.TWO
View MorePerformance Overview: 6892.TWO
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6892.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6892.TWO
View MoreValuation Measures
Market Cap
2.80B
Enterprise Value
2.55B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
25.87
Price/Book (mrq)
2.75
Enterprise Value/Revenue
25.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-4.73
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--